Biohaven Pharmaceutical Holding Company Ltd

NYSE:BHVN   3:59:57 PM EDT
100.33
-4.69 (-4.47%)
Products

FDA Approves Biohaven's Nurtec® Odt (Rimegepant) For Prevention Now The First And Only Migraine Medication For Both Acute And Preventive Treatment

Published: 05/27/2021 21:47 GMT
Biohaven Pharmaceutical Holding Company Ltd (BHVN) - FDA Approves Biohaven's Nurtec® Odt (rimegepant) for Prevention: Now the First and Only Migraine Medication for Both Acute and Preventive Treatment.